Global innovation and intellectual property rights lobbies often castigate India for its weak intellectual property framework that fails to recognise innovation and grant patents.

Majority of pharmaceutical drug patents granted by India might have skipped elaborate scrutiny, an analysis of patent grants by a team of researchers and patent lawyers reveals.

OVER the last few decades, people in the developing world have been rejecting the intellectual property (IP) regime as it has been increasingly imposed on them following the establishment of the World Trade Organisation (WTO), including its trade-related intellectual property rights (TRIPs) regime.  

India’s rejection of secondary patents has kept blockbuster medicines affordable for many

Is the current patent system the best way to encourage meaningful research? From the vantage of economics, views both pro and con have been expressed.